JAK1 and primary cutaneous T-cell non-Hodgkin lymphoma: Deregulated JAK/STAT signaling due to JAK1 and JAK3 somatic mutations has been observed in Cutaneous T-Cell Lymphoma (CTCL) (Perez et al., 2015).